Read + Share
Amedeo Smart
Independent Medical Education
Iwase M, Ando M, Aogi K, Aruga T, et al. Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast Cancer Res Treat 2020 Mar 5. pii: 10.1007/s10549-020-05580.PMID: 32140811
Email
LinkedIn
Facebook
Twitter
Privacy Policy